UK’s NICE recommends AbbVie’s Aquipta to treat migraines
Pharmaceutical Technology
APRIL 11, 2024
The oral drug, which gained UK approval in September 2023, is used for the prevention of both chronic and episodic migraines.
Thu.Apr 11, 2024
244 
DTAB recommends prohibiting pain relief combination S(+) etodolac+paracetamol
AuroBlog - Aurous Healthcare Clinical Trials blog
APRIL 11, 2024
The Drugs Technical Advisory Board (DTAB) of the Union health ministry has once again recommended prohibiting the manufacture, sale and distribution of pain relief drug combination S(+) etodolac+paracetamol, after considering a sub-committee report.
Join 21,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
US sues Regeneron, alleging false price reporting on Eylea
Bio Pharma Dive
APRIL 11, 2024
The lawsuit claims the drugmaker didn’t disclose reimbursement to drug distributors for credit card fees, artificially inflating the reported price of the blockbuster eye drug.
Radical Vaccine Strategy Could Help Quash Parasite Afflicting Millions
AuroBlog - Aurous Healthcare Clinical Trials blog
APRIL 11, 2024
Using viruses that infect bacteria to detect proteins sprouted by a notorious parasite, scientists have honed in on possible vaccine targets for schistosomiasis, a neglected tropical disease that currently affects an estimated 600 million people worldwide, causing 280,000 deaths per year.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Century buys a startup, raises funding in cell therapy expansion
Bio Pharma Dive
APRIL 11, 2024
The biotech is acquiring Clade Therapeutics and its stem cell technology at a discount price, while adding $60 million via a private placement led by Bain Capital.
Researchers call to reduce repeat antibiotic prescriptions for respiratory tract infections
Pharma Times
APRIL 11, 2024
RTIs account for around 60% of global antibiotic prescribing and are a key driver of AMR
Sign up to get articles personalized to your interests!
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
More Trending
Number of ongoing US drug shortages reaches new high, pharmacist group says
Fierce Pharma
APRIL 11, 2024
As lawmakers, biopharma companies and others try to stabilize vulnerable pharma supply chains, drug shortages have become about as bad as they’ve ever been in the U.S. | The American Society of Health-System Pharmacists has released new data showing there were 323 drugs in shortage in the U.S. as of 2024’s first quarter—the highest number recorded since ASHP began tracking shortage data back in 2001.
Rallybio and J&J collaborate to tackle maternal-foetal blood disorder
Pharmaceutical Technology
APRIL 11, 2024
The collaboration pact will see Rallybio gaining a $6.6m equity investment from J&J to further a natural history study of FNAIT.
FDA commissioner tells lawmakers his agency needs more authority to prevent drug shortages
Fierce Pharma
APRIL 11, 2024
After investigations into the FDA’s response to severe drug shortages and other issues, the House Committee on Oversight and Accountability finally had its long-awaited chance to grill the agency’s | FDA Commissioner Robert Califf, M.D., told lawmakers that the agency, as the "referee," needs to be given more authority in order to preemptively halt drug shortages.
Pharmaceutical filtration and purification solutions for the pharmaceutical industry
Pharmaceutical Technology
APRIL 11, 2024
Pharmaceutical Technology has listed the leading suppliers of pharmaceutical filtration equipment and purification solutions. Download here.
Regeneron hit with DOJ complaint that it hid 'hundreds of millions' in Eylea credit card processing fees from Medicare
Fierce Pharma
APRIL 11, 2024
The U.S. government is accusing Regeneron of deliberately using an unusual method to overcharge Medicare for the company’s popular eye drug Eylea. | The U.S. government is accusing Regeneron of deliberately using an unusual method to overcharge Medicare for the company’s popular eye drug Eylea.
OSE wins French govt grant for Phase III trial for cancer vaccine
Pharmaceutical Technology
APRIL 11, 2024
The $9m French funding is for Phase III registrational trial for OSE’s Tedopi as a second-line treatment for NSCLC.
UK study finds screening with a PSA test in prostate cancer can lead to overdiagnosis
Pharma Times
APRIL 11, 2024
Prostate cancer is responsible for around 12,000 deaths a year in the UK and is the second biggest cause of death for men
Surges in obesity drugs forecast to enter US market
Pharmaceutical Technology
APRIL 11, 2024
Over the past two decades, there has been a marked increase in obesity rates among US adults, with projections indicating a continuing upward trend.
The New Age of Decentralized Clinical Trials
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
How to overcome hurdles to HCP and patient adoption of digital health initiatives
pharmaphorum
APRIL 11, 2024
Discover effective strategies to overcome barriers to healthcare providers (HCP) and patients adopting digital health initiatives like apps. Learn how to increase engagement and improve outcomes.
Addressing key challenges in HPAPI manufacturing
Pharmaceutical Technology
APRIL 11, 2024
With specialised production facilities for HPAPIs in great demand, what are the key challenges in manufacturing?
Pfizer settles 12-year-old lawsuit in alleged pay-for-delay scheme for $39M
Fierce Pharma
APRIL 11, 2024
In a case so old that it predates Pfizer’s 2009 acquisition of Wyeth, the companies and a class-action group of direct drug purchasers have agreed to
Drug delivery innovations push forth women’s health
Pharmaceutical Technology
APRIL 11, 2024
From nanoparticles to transdermal patches, Pharmaceutical Technology takes a look at the latest in drug delivery technologies for women's health.
FDA puts breakthrough tag on Roche, Lilly Alzheimer’s test
pharmaphorum
APRIL 11, 2024
Roche and Eli Lilly have been granted breakthrough status by the FDA for their pTau217 blood test for Alzheimer's disease.
Eli Lilly under pressure: Can they solve GLP-1 supply squeeze?
BioPharma Reporter
APRIL 11, 2024
Specific doses of Eli Lillyâs GLP-1 blockbuster drugs Mounjaro and Zepbound are currently facing a supply shortage, and frustrated patients are urging the pharma giant to act â fast.
Novartis adds clinical-stage protein degrader from Arvinas
pharmaphorum
APRIL 11, 2024
Novartis accelerates its protein degrader programmes by licensing a phase 3-ready prostate cancer candidate from Arvinas in a deal worth over $1 billion
In Alzheimer’s Dementia, Should EEG Be Used as a Functional Biomarker of Target Engagement and Organizational Change When Evaluating Treatment Efficacy?
XTalks
APRIL 11, 2024
Approaches to help better understand the complexities of brain function are key to advancing the development of novel treatments for Alzheimer’s disease. In recent years, researchers have increasingly recognized the value of biomarkers in Alzheimer’s disease in several areas, including offering biological insights into the disease’s pathophysiology, developing diagnostic tools for earlier disease detection, monitoring disease progression and evaluating the efficacy of new treatments.
The New Age of Decentralized Clinical Trials
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Green shoots and cautious optimism: Insights from BIO-Europe Spring
pharmaphorum
APRIL 11, 2024
Discover the latest insights and trends from BIO-Europe Spring conference, focusing on green shoots and cautious optimism in the industry. Learn about the latest funding opportunities and more.
Innovative Financing Models for Repurposing Generic Drugs
Drug Patent Watch
APRIL 11, 2024
A paper presented at the 2nd International Conference on Systems Medicine, AI, and Drug Repurposing proposes a novel approach to overcoming the financial barriers associated with repurposing generic drugs through… Source
EU pharma reform package clears key Parliament vote
pharmaphorum
APRIL 11, 2024
The European Parliament has voted through reforms to legislation regulating the pharma sector, which the industry claims could compromise competitiveness and patient care.
Pharma Pulse 4/11/24: In Battle Over Health Care Costs, Private Equity Plays Both Sides, Psychedelic Medicine Could Fill Care Gap & more
Pharmaceutical Commerce
APRIL 11, 2024
The latest news for pharma industry insiders.
Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
US accuses Regeneron of fraud in Eylea price reporting
pharmaphorum
APRIL 11, 2024
US files a lawsuit against Regeneron, accusing the pharma company of fraudulent price reporting for ophthalmology drug Eylea
Vertex Buys Alpine for $4.9B to Bolster Autoimmune and Inflammatory Disease Pipeline
BioSpace
APRIL 11, 2024
Vertex Pharmaceuticals on Wednesday announced it is acquiring clinical-stage immunotherapy company Alpine Immune Sciences for $4.9 billion in cash, the largest acquisition so far this year.
NICE backs AbbVie’s oral therapy for migraine prevention
pharmaphorum
APRIL 11, 2024
AbbVie’s Aquipta has become the first oral therapy for chronic and episodic migraine prevention to be recommended by NICE for NHS use.
Fujifilm Diosynth blueprints another $1.2B expansion at North Carolina plant where it aims to employ 1,400
Fierce Pharma
APRIL 11, 2024
As the contract manufacturing industry stands at a crossroads, certain CDMOs are prospering while other stalwarts are going the sell-off route or warding off political and economic threats to their | Fujifilm Diosynth is investing $1.2 billion more to soup up its end-to-end biomanufacturing facility in Holly Springs, North Carolina, bringing the total project to more than $3.2 billion, the company said Thursday.
How Machine Learning Drives Clinical Trial Efficiency
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Let's personalize your content